Malaria Research Today is a free monthly online journal that collates and summarizes the latest research about Malaria, including details on prevention, treatment, causes, mosquitoes.

Volume 6 (2009), Issue 6 (June)

1. Plasmodium yoelii: adverse outcome of non-lethal P. yoelii malaria during co-infection with Schistosoma mansoni in BALB/c mouse model.
   Exp Parasitol, 122(3): 254-9. [Abstract] [Full-text]
2. Low density parasitaemia, red blood cell polymorphisms and Plasmodium falciparum specific immune responses in a low endemic area in northern Tanzania.
   BMC Infect Dis, 9: 69. [Abstract] [Full-text]
3. Prevalence of malaria in pregnant women in Lagos, South-West Nigeria.
   Korean J Parasitol, 47(2): 179-83. [Abstract] [Full-text]
4. Drug resistance and in vitro susceptibility of Plasmodium falciparum in Thailand during 1988-2003.
   Korean J Parasitol, 47(2): 139-44. [Abstract] [Full-text]
5. Malaria diagnosis: a brief review.
   Korean J Parasitol, 47(2): 93-102. [Abstract] [Full-text]
6. Human monoclonal IgG selection of Plasmodium falciparum for the expression of placental malaria-specific variant surface antigens.
   Parasite Immunol, 31(6): 341-6. [Abstract] [Full-text]
7. Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment.
   Proc Natl Acad Sci U S A, 106(22): 9027-32. [Abstract] [Full-text]
8. Development of a stable positive control to be used for quality assurance of rapid diagnostic tests for malaria.
   Diagn Microbiol Infect Dis, 64(3): 256-60. [Abstract] [Full-text]
9. Malaria prevention in Sub-Saharan Africa: a field study in rural Uganda.
   J Community Health, 34(4): 288-94. [Abstract] [Full-text]
10. Imported malaria among African immigrants: is there still a relationship between developed countries and their ex-colonies?
    Malar J, 8: 111. [Abstract] [Full-text]
11. Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India.
    Malar J, 8: 107. [Abstract] [Full-text]
12. Utilization, retention and bio-efficacy studies of PermaNet in selected villages in Buie and Fentalie districts of Ethiopia.
    Malar J, 8: 114. [Abstract] [Full-text]
13. Factors related to compliance to anti-malarial drug combination: example of amodiaquine/sulphadoxine-pyrimethamine among children in rural Senegal.
    Malar J, 8: 118. [Abstract] [Full-text]
14. Detection of Plasmodium sp. in capybara.
    Vet Parasitol, 163(1): 148-51. [Abstract] [Full-text]
15. Epidemiological situation of malaria in Madagascar: baseline data for monitoring the impact of malaria control programmes using serological markers.
    Acta Trop, 111(2): 160-7. [Abstract] [Full-text]
16. Nanoencapsulation increases quinine antimalarial efficacy against Plasmodium berghei in vivo.
    Int J Antimicrob Agents, 34(2): 156-61. [Abstract] [Full-text]
17. Cellular tumor necrosis factor, gamma interferon, and interleukin-6 responses as correlates of immunity and risk of clinical Plasmodium falciparum malaria in children from Papua New Guinea.
    Infect Immun, 77(7): 3033-43. [Abstract] [Full-text]
18. Endothelial nitric oxide synthase gene polymorphisms and Plasmodium falciparum infection in Indian adults.
    Infect Immun, 77(7): 2943-7. [Abstract] [Full-text]
19. Malaria as a cause of morbidity and mortality in children with homozygous sickle cell disease on the coast of Kenya.
    Clin Infect Dis, 49(2): 216-22. [Abstract] [Full-text]
20. Positive selection of a CD36 nonsense variant in sub-Saharan Africa, but no association with severe malaria phenotypes.
    Hum Mol Genet, 18(14): 2683-92. [Abstract] [Full-text]
21. Quinine monotherapy for treating uncomplicated malaria in the era of artemisinin-based combination therapy: an appropriate public health policy?
    Lancet Infect Dis, 9(7): 448-52. [Abstract] [Full-text]
22. Evaluation of Artemisia annua infusion efficacy for the treatment of malaria in Plasmodium chabaudi chabaudi infected mice.
    Exp Parasitol, 122(4): 344-8. [Abstract] [Full-text]
23. Liquid chromatographic tandem mass spectrometric assay for quantification of 97/78 and its metabolite 97/63: a promising trioxane antimalarial in monkey plasma.
    J Chromatogr B Analyt Technol Biomed Life Sci, 877(22): 2074-80. [Abstract] [Full-text]

© 2004-2010 Malaria Research Today. All Rights Reserved.